Is it lymphoma or lymphomatoid papulosis? - 11/09/11
Doi : 10.1016/S0190-9622(97)80330-1
Marie-France Demierre, MD, FRCPC a, Lynne J. Goldberg, MD a, b, Marshall E. Kadin, MD e, Howard K. Koh, MD, MPH a, c, d, ⁎
a Department of Dermatology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA
b Section of Dennatopathology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, USA
c Department of Medicine, Boston University Schools of Medicine and Public Health, Boston, Massacusetts, USA
d Departments of Epidemiology and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, Massacusetts, USA
e Department of Pathology, Beth Israel Hospital, Harvard Medical School, Boston, Massacusetts, USA
*Reprint requests: Howard K. Koh, MD, MPH, FACP, Professor of Dermatology, Medicine and Public Health, Boston University Medical Center, 720 Harrison Ave., D.O.B. 801A, Boston, MA 02118-2334.
Abstract |
Distinguishing malignancy from premalignant conditions can be difficult. Controversy surrounds both the clinical and histologic criteria used to distinguish lymphomatoid papulosis, a benign disorder, from CD30+ anaplastic large-cell lymphoma. Three case histories illustrate important points in categorizing different lymphoproliferative disorders as benign or malignant. We emphasize a multidisciplinary approach to improve diagnosis and patient management.
Le texte complet de cet article est disponible en PDF.© 1997
Publié par Elsevier Masson SAS.
Vol 36 - N° 5
P. 765-772 - mai 1997 Retour au numéro
Article précédent
- Adjuvant therapy for cutaneous malignant melanoma
- Marie-France Demierre, Howard K. Koh
- Surgical Pearl: The hybrid mattress suture
- Mark D. Hoffman, Kenneth B. Bielinski
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?